Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Insulin gene expression in adult-onset nesidioblastosis.
Fuller PJ, Ehrlich AR, Susil B, Zeimer H. Fuller PJ, et al. Among authors: susil b. Clin Endocrinol (Oxf). 1997 Aug;47(2):245-50. doi: 10.1046/j.1365-2265.1997.2371046.x. Clin Endocrinol (Oxf). 1997. PMID: 9302402
The inhibins and ovarian cancer.
Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, Neva P, Robertson DM. Burger HG, et al. Among authors: susil b. Mol Cell Endocrinol. 2001 Jun 30;180(1-2):145-8. doi: 10.1016/s0303-7207(01)00519-6. Mol Cell Endocrinol. 2001. PMID: 11451584 Review.
Molecular characterization of sarcomatous change in a granulosa cell tumor.
McNeilage J, Alexiadis M, Susil BJ, Mamers P, Jobling T, Laslett G, Trajstman A, Fuller PJ. McNeilage J, et al. Among authors: susil bj. Int J Gynecol Cancer. 2007 Mar-Apr;17(2):398-406. doi: 10.1111/j.1525-1438.2006.00865.x. Epub 2007 Feb 19. Int J Gynecol Cancer. 2007. PMID: 17316362
Inhibin and ovarian cancer.
Burger HG, Baillie A, Drummond AE, Healy DL, Jobling T, Mamers P, Robertson DM, Susil B, Cahir N, Shen Y, Verity K, Fuller PJ, Groome NP, Findlay JK. Burger HG, et al. Among authors: susil b. J Reprod Immunol. 1998 Aug;39(1-2):77-87. doi: 10.1016/s0165-0378(98)00014-x. J Reprod Immunol. 1998. PMID: 9786454
[Inhibin and ovarian cancer].
Burger HG, Baillie A, Drummond AE, Healy DL, Jobling T, Mamers P, Robertson DM, Susil B, Cahir N, Shen Y, Verity K, Fuller PJ, Groome NP, Findlay JK. Burger HG, et al. Among authors: susil b. Vopr Onkol. 1999;45(4):369-73. Vopr Onkol. 1999. PMID: 10532093 Russian.
Endometrial cancer.
Ryan AJ, Susil B, Jobling TW, Oehler MK. Ryan AJ, et al. Among authors: susil b. Cell Tissue Res. 2005 Oct;322(1):53-61. doi: 10.1007/s00441-005-1109-5. Epub 2005 Nov 3. Cell Tissue Res. 2005. PMID: 15947972 Review.
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Kang EY, Cheasley D, LePage C, Wakefield MJ, da Cunha Torres M, Rowley S, Salazar C, Xing Z, Allan P, Bowtell DDL, Mes-Masson AM, Provencher DM, Rahimi K, Kelemen LE, Fasching PA, Doherty JA, Goodman MT, Goode EL, Deen S, Pharoah PDP, Brenton JD, Sieh W, Mateoiu C, Sundfeldt K, Cook LS, Le ND, Anglesio MS, Gilks CB, Huntsman DG, Kennedy CJ, Traficante N; Australian Ovarian Cancer Study; DeFazio A, Kaufmann S, Churchman M, Gourley C, Stephens AN, Meagher NS, Ramus SJ, Antill YC, Campbell I, Scott CL, Köbel M, Gorringe KL; GAMuT Collaborators. Kang EY, et al. Mod Pathol. 2021 Jan;34(1):194-206. doi: 10.1038/s41379-020-0618-9. Epub 2020 Jul 28. Mod Pathol. 2021. PMID: 32724153 Free PMC article.
51 results